[go: up one dir, main page]

FI941447L - Suun kautta annettavat, kapseleina olevat ubidekarenonivalmisteet - Google Patents

Suun kautta annettavat, kapseleina olevat ubidekarenonivalmisteet Download PDF

Info

Publication number
FI941447L
FI941447L FI941447A FI941447A FI941447L FI 941447 L FI941447 L FI 941447L FI 941447 A FI941447 A FI 941447A FI 941447 A FI941447 A FI 941447A FI 941447 L FI941447 L FI 941447L
Authority
FI
Finland
Prior art keywords
ubidecarenone
preparations
oral
capsule form
capsule
Prior art date
Application number
FI941447A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI941447A7 (fi
FI941447A0 (fi
Inventor
Roberto Seghizzi
Giuseppe Furiosi
Original Assignee
Inverni Della Beffa Farma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inverni Della Beffa Farma filed Critical Inverni Della Beffa Farma
Publication of FI941447A0 publication Critical patent/FI941447A0/fi
Publication of FI941447L publication Critical patent/FI941447L/fi
Publication of FI941447A7 publication Critical patent/FI941447A7/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI941447A 1993-03-30 1994-03-29 Suun kautta annettavat, kapseleina olevat ubidekarenonivalmisteet FI941447A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI930605A IT1263840B (it) 1993-03-30 1993-03-30 Formulazioni orali di ubidecarenone in forma di capsule

Publications (3)

Publication Number Publication Date
FI941447A0 FI941447A0 (fi) 1994-03-29
FI941447L true FI941447L (fi) 1994-10-01
FI941447A7 FI941447A7 (fi) 1994-10-01

Family

ID=11365545

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941447A FI941447A7 (fi) 1993-03-30 1994-03-29 Suun kautta annettavat, kapseleina olevat ubidekarenonivalmisteet

Country Status (7)

Country Link
US (1) US5443842A (it)
EP (1) EP0617957A1 (it)
JP (1) JPH0769874A (it)
KR (1) KR940021054A (it)
AU (1) AU5911994A (it)
FI (1) FI941447A7 (it)
IT (1) IT1263840B (it)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10133305B4 (de) * 2001-07-12 2004-06-03 Aquanova German Solubilisate Technologies (Agt) Gmbh Ubichinon Konzentrat
JP3822479B2 (ja) 2001-10-10 2006-09-20 株式会社カネカ 還元型補酵素q水溶液の安定化組成
MXPA06011871A (es) 2004-04-15 2007-10-08 Chiasma Inc Composiciones capaces de facilitar la penetracion a traves de una barrera biologica.
CA2587677C (en) 2004-11-16 2013-05-28 Bioavailability, Inc. High concentration self-microemulsifying coenzyme q10 preparations for nutritional use
US8252326B2 (en) * 2005-06-01 2012-08-28 Catalent Australia Pty Ltd. Self-microemulsifying dosage forms of low solubility active ingredients such as co-enzyme Q10
EP1912730A2 (en) * 2005-07-28 2008-04-23 Isp Investments Inc. Method to improve characteristics of spray dried powders and granulated materials, and the products thereby produced
KR101320016B1 (ko) * 2005-12-14 2013-10-29 주식회사 대웅 안정화된 코엔자임q10, 종합 비타민 및 미네랄 성분을함유하는 복합제제
MX2008009652A (es) * 2006-01-24 2008-11-06 R Tech Ueno Ltd Composicion farmaceutica que comprende un compuesto biciclico y metodo para estabilizar el compuesto biciclico.
MY153288A (en) * 2006-06-28 2015-01-29 Hovid Berhad An effective pharmaceutical carrier for poorly bioavailable drugs
WO2008076780A2 (en) * 2006-12-14 2008-06-26 Isp Investments Inc. Amorphous valsartan and the production thereof
US8613946B2 (en) * 2006-12-21 2013-12-24 Isp Investment Inc. Carotenoids of enhanced bioavailability
US20080181961A1 (en) * 2007-01-26 2008-07-31 Isp Investments, Inc. Amorphous oxcarbazepine and the production thereof
CN101622302B (zh) * 2007-01-26 2013-01-23 Isp投资公司 生产喷雾干燥产品的制剂工艺方法
KR100869444B1 (ko) * 2007-07-11 2008-11-18 주식회사 중외제약 유비데카레논을 함유하는 다층정 비타민 복합제제
US20090060993A1 (en) * 2007-09-04 2009-03-05 Joseph Schwarz Solid pharmaceutical composition for enhanced delivery of coenzyme q-10 and ubiquinones
RU2678833C2 (ru) 2008-09-17 2019-02-04 Киазма Инк. Фармацевтические композиции и соответствующие способы доставки
HUE071943T2 (hu) 2015-02-03 2025-10-28 Amryt Endo Inc Akromegália kezelése oktreotid orális alkalmazásával
FR3037246B1 (fr) * 2015-06-09 2017-07-21 Laboratoires Iphym Composition comprenant un extrait de chrysanthellum et de l'ubidecarenone
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5581813A (en) * 1978-12-16 1980-06-20 Nisshin Flour Milling Co Ltd Composition containing coenzyme q10 and its perparation
JPS55153717A (en) * 1979-05-18 1980-11-29 Tokai Kapuseru Kk Preparation of ubidecarenone soft capsule
JPS59148718A (ja) * 1983-02-10 1984-08-25 Fujisawa Pharmaceut Co Ltd ユビデカレノン組成物
DE3582439D1 (de) * 1984-01-28 1991-05-16 Roshdy Ismail Mittel zur behandlung von herzerkrankungen.
IT1191608B (it) * 1985-02-01 1988-03-23 Zambon Spa Composizione farmaceutica e forme farmaceutiche che la contengono
US5140021A (en) * 1986-04-16 1992-08-18 Genesis Systems Corporation Method and dosage form for treatment of premenstrual syndrome
JPH0774145B2 (ja) * 1986-12-15 1995-08-09 株式会社資生堂 結晶性薬物含有乳化組成物
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
GB8701332D0 (en) * 1987-01-21 1987-02-25 Lilly Industries Ltd Capsule filling
KR880012221A (ko) * 1987-04-13 1988-11-26 사노 가즈오 에스테르 또는 아미드를 활성성분으로 함유하는 약제 조성물
DE3738236A1 (de) * 1987-11-11 1989-05-24 Euro Celtique Sa Beisskapsel
FI96169C (fi) * 1989-07-10 1996-05-27 Eisai Co Ltd Menetelmä polyprenyyliyhdistettä sisältävän farmaseuttisen koostumuksen valmistamiseksi
IT1250672B (it) * 1991-07-11 1995-04-21 Idb Holding Spa Formulazioni orali di ubidecarenone in soluzione acquosa
US5206219A (en) * 1991-11-25 1993-04-27 Applied Analytical Industries, Inc. Oral compositions of proteinaceous medicaments

Also Published As

Publication number Publication date
ITMI930605A0 (it) 1993-03-30
JPH0769874A (ja) 1995-03-14
US5443842A (en) 1995-08-22
KR940021054A (ko) 1994-10-17
ITMI930605A1 (it) 1994-09-30
FI941447A7 (fi) 1994-10-01
AU5911994A (en) 1994-10-06
FI941447A0 (fi) 1994-03-29
EP0617957A1 (en) 1994-10-05
IT1263840B (it) 1996-09-04

Similar Documents

Publication Publication Date Title
DE68913415D1 (de) Oral-Präparate.
DE69006068D1 (de) Oral verabreichbare Ibuprofen enthaltende Mittel.
DE68909974D1 (de) Orales Präparat gegen Zahnstein.
FI941447L (fi) Suun kautta annettavat, kapseleina olevat ubidekarenonivalmisteet
DK0539319T3 (da) Farmaceutisk cyclosporinpræparat
MX9203480A (es) Formulaciones medicinales en aereosol.
DE69518331D1 (de) Orale zubereitungen
DE69014358D1 (de) Kosmetisches Präparat.
DE68903192D1 (de) Orale praeparate.
DK314089D0 (da) Orale praeparater
FI964285L (fi) Taksaanien luokkaan kuuluviin johdannaisiin perustuvat farmaseuttiset valmisteet
NO943264D0 (no) Naturlig vitamin E-preparat
ATE186541T1 (de) Quillajasaponin-zusatz und diesen enthaltende impfstoffformulierung
IL104236A0 (en) Oral anti-halitosis preparations
FI954986L (fi) Uudet, suun kautta annettavat, syklosporiinia sisältävät farmaseuttiset valmisteet
DE68905091D1 (de) Kosmetisches praeparat.
TR199501082A2 (tr) Farmasötik formülasyonlar.
DE69432149D1 (de) Orale Zubereitungen
ATE298576T1 (de) Arzneizubereitungen
IS5062A (is) Lyfjablöndur sem innihalda afleiður N-súlfonýlindólíns
ITMI941169A0 (it) Formulazioni farmaceutiche
EE9800275A (et) Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid
FI951155L (fi) Farmaseuttinen valmiste
ATE237309T1 (de) Arzneizubereitungen
EP1142589A4 (en) Medicinal preparations